Ankyra Therapeutics
Ankyra is developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Signals
X account@ankyratx · created Feb 17, 2022 (4 years old) · 40 followers
Website registeredNov 21, 2019 (7 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
DI
Darrell Irvine FounderKD
K. Dane Wittrup FounderHL
Howard L. Kaufman President and Chief Executive OfficerMS
Michael Schmidt Chief Scientific OfficerRV
Robert V. Tighe Chief Scientific OfficerSB
Sailaja Battula Chief Scientific OfficerSG
Stephen Gorgol Chief Financial Officer
Investors
BBorealis Ventures
FFidelity
GGV
- MMithril Capital
PPolaris
SSands Capital Ventures
SSpring Mountain Capital
Companies like Ankyra Therapeutics
BBiosapienSeries A · Jan 2025
MMemo Therapeutics$22M Series B+ · May 2024NNormunity$75M Series B+ · Jan 2025
CCatalYm$150M Series B+ · Jul 2024
TTinkeso Therapeutics
EEnodaSeries A · Jul 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ankyra-therapeutics (get a free API key).